DMU-16/55/RC/Testing of Drugs/2016/CS ESIC Re E-Tender

DMU-16/55/RC/Testing of Drugs/2016/CS ESIC Re E-Tender

Re-e-Tender Enquiry No.: DMU-16/55/RC/Testing of Drugs/2016/CS ESIC Re e-Tender enquiry form for Rate Contract for Testing Of Drugs e-Tender enquiry form (Free of cost) CENTRAL STORES, DIRECTORATE (MEDICAL) DELHI ESI DISPENSARY COMPLEX, TILAK VIHAR, NEW DELHI-110018 Phone No.28335358 & 28335360, Fax 28335357 LAST DATE OF SUBMISSION OF ONLINE e-TENDER 16/08/2018. Page 1 of 112 Name of the Re-e-Tender : DMU-16/55/ RC/ Testing of Drugs /2016/CS IMPORTANT INSTRUCTIONS FOR BIDDERS REGARDING ONLINE PAYMENT All bidders/contractors are required to procure class IIIB digital Signature Certificate (DSC) with both DSC components i.e. signing and encryption to participate in the E-tenders. Bidders should get registered at https://esictenders.eproc.in. Bidders should add the below mentioned sites under Internet Explorer → Tools → Internet Options → Security → Trusted Sites → Sites of Internet Explorer : https://esictenders.eproc.in https://www.tpsl-india.in https://www4.jpg-online.com Also , Bidders need to select “Use TLS 1.1 and Use TLS 1.2” under Internet Explorer → Tools → Internet Options → Advanced Tab → Security. Bidder needs to submit Bid processing Fee charges of Rs.2495/-(Non Refundable) in favour of M/S C1 India Pvt. Ltd. Payable at New Delhi via Online Payment Modes such as Debit Card, Credit Card or NetBanking for participating in the tender. Bidders can contact our Helpdesk at https://esictenders.eproc.in/html/Support.asp Page 2 of 112 Re-e-Tender Enquiry No.: DMU-16/55/RC/Testing of Drugs/2016/CS CONTENTS Sr. Headings Page No. No. 1 Date Sheet 4 2 e-Tender enquiry 1-112 3 Instructions to Bidders 6-8 4 Conditions of Contract 9-17 5 Schedule of Requirement 18 6 Technical Bid (Annexure-T) 19 7 Price Bid (Annexure-P) 20 8 Contract Form 21 9 Affidavit of the Laboratory (Annexure-A) 22-24 10 Undertaking (Annexure-B) 25 11 Mandate Form (Annexure-C) 26 12 Bank Guarantee Form For Performance Security(Annexure-D) 27 13 Lowest Rate Certificate (Annexure-E) 28 14 Checklist of the Documents (Annexure-F) 29 15 LIST OF ITEMS (Annexure-S) 30-112 Helpdesk contact No. 28335358 & 28335360, Fax 28335357 Page 3 of 112 Re-e-Tender Enquiry No.: DMU-16/55/RC/Testing of Drugs/2016/CS e-TENDER Date Sheet Name of the e-Tender : DMU-16/55/RC/Testing of Drugs/2016/CS Dated: 17/07/2018 For Testing of Drugs Sr. Details Dates & time No. 1. Period of availability of e-Tender Enquiry document on ESIC website- www.esic.nic.in 17.07.2018 to 16.08.2018 up to 11.00AM and www.dmdesic.nic.in CPP Portal- www.eprocure.gov.in and ESIC e-Procurement portal- https://esictenders.eproc.in 2. Pre-bid meeting 24.07.2018 at 11.00AM at Conference hall, Directorate (Medical) Delhi, Tilak Vihar, New Delhi – 110018. 3. Last date of Manual and Online Technical Bid 16.08.2018 up to 11.00AM submission 4(i). Opening of Manual Bid and Online Technical 16.08.2018 at 11.30AM at Conference hall, Bid Directorate (Medical) Delhi, Tilak Vihar, New Delhi – 110018. 4(ii) Result of Technical Bid Will be Communicated over Phone/Email/SMS to the Bidders. 4(iii) Representation w.r.t. Technical Bid Will be accepted only within 3 working days of the declaration of result. 5. Opening of Online Price Bid At 11:00A.M. at Conference hall, Directorate (Medical) Delhi, Tilak Vihar, New Delhi – 110018 and information will be communicated to Technically eligible Bidders over Phone/Email/SMS. 6. Validity of offer 365 days from the last date of submission of e-Tender If the date of opening of tenders is declared a public holiday, the tenders shall be opened on the next working day at the same venue and time. However, the bid shall be accepted at the site of ESIC e-Procurement portal- https://esictenders.eproc.in as per the original schedule, without extension. All tenderers are requested to check further notifications / updates if any on ESIC website- www.esic.nic.in, www.dmdesic.nic.in & ESIC e-Procurement portal - https://esictenders.eproc.in . Page 4 of 112 Re-e-Tender Enquiry No.: DMU-16/55/RC/Testing of Drugs/2016/CS Re-e-Tender Enquiry EMPLOYEE STATE INSURANCE CORPORATION Room No.5,8,Central Stores, Directorate(Medical)Delhi, Tilak Vihar, New Delhi-110018. Subject: Formation of ESIC RATE CONTRACT for “Testing of Drugs” for use in ESI Institutions in Delhi/New Delhi/Noida region valid for two years from the date of finalization. 1. E- Tender is hereby invited by Manager Stores Central Stores on behalf of Director(Medical)Delhi under two bid system, only from NABL accredited Laboratories located in the National Capital Territory of Delhi and adjoining cities of Noida, Gurugram, Faridabad and Ghaziabad, for formation of ESIC Rate Contract for Testing of Drugs through e-procurement portal of ESIC-https://esictenders.eproc.in for the purpose of providing safe & potent drugs & dressings to the beneficiaries, for a period of Two years. The Hard copy of following documents in a sealed envelope super scribed as e-Tender No.DMU-16/55/RC/Testing of Drugs/2016/CS are to be submitted:- 1.1 EMD as Specified in the Instructions to Bidders. 1.2 Affidavits/ Authorization letter as per clause 5 of Tender document. 2. E-Tender Enquiry Form may be viewed online or downloaded by the bidders from the website – www.esic.nic.in & www.dmdesic.nic.in, www.eprocure.gov.in and https://esictenders.eproc.in. 2.1 It is mandatory for all bidders to have valid Class III B Digital Signature Certificate (both with signing and encryption component) from any certifying agency as per Information Technology (IT) Act, 2000 for submitting e-bid at the ESIC e-procurement Portal https://esictenders.eproc.in. Bidders can contact helpdesk at https://esictenders.eproc.in/html/support.asp. 2.2 Bidders should get registered at https://esictenders.eproc.in. 2.3 Notwithstanding this, evaluation & finalization of Rate Contract will be based on e- bid submitted by the tenderer. It will be the sole responsibility of the tenderer to scan and upload clear and legible documents for assessment, failing which the tender will be liable for rejection. 3. It is proposed to enter into a Running Rate Contract with Laboratories which fulfill the eligibility criteria approved by ESI Corporation for Testing of Drugs enumerated in the schedule annexed. The eligibility criteria have been given in the terms and conditions. Laboratories intending to participate in the Rate Contract should first ensure that they fulfill all the eligibility criteria as prescribed under the terms and conditions, otherwise the tenders will be summarily rejected. Tenderer should quote only for the items for which they fulfill all the eligibility criteria. 4. The Rate Contract will be governed by the Terms and Conditions enclosed with this Tender Enquiry and no modifications/alterations etc. are allowed in any case. If any modification/alteration is proposed or any other condition advanced by the tenderer is subject to acceptance by the Tender Inviting Authority, Director(Medical) Delhi. Page 5 of 112 Re-e-Tender Enquiry No.: DMU-16/55/RC/Testing of Drugs/2016/CS I. Instruction to Bidders 5. Signing of the tender The tender is liable to be rejected if complete information is not given therein or if the particulars and date (if any) asked for in the schedule to the tender are not filled in. Individual signing the tenders or other documents connected with the bidding process must specify whether he signs as:- i) A sole proprietor of the Laboratory or constituted Attorney of such sole proprietor. ii) A partner of the Laboratory, if it be in partnership, in which case he must have authority to refer to arbitration disputes concerning the business of the partnership/agreement or a power of attorney. iii) Constituted Attorney of the Laboratory if it is a company. N.B. 5.1 In case of Authorized representative, authorization letter on the letter head of the laboratory duly signed and stamped by proprietor needs to be submitted. 5.2 In case of (ii) a copy of partnership agreement attested by a Notary Public should be furnished unless the same has been previously furnished to the Corporation, or affidavit on stamped paper of all the partners admitting execution of the partnership of the general power of attorney should be furnished. 5.3 In the case of Laboratory run in partnership, where no authority to refer disputes concerning the business of the partnership has been conferred on any partner, the documents must be signed by every partner of the Laboratory. 5.4 A person signing the documents in the Bidding process forming part of the contract on behalf of another shall be deemed to warrant that he has authority to sign the same and, if on enquiry it appears that the person so signing had no authority to do so, the purchaser may without prejudice to other civil and criminal remedy cancel the contract and hold the signatory liable for all costs and damages. 5.5 Each and every page of the document uploaded/submitted in the bidding process should be signed and stamped by the authorized signatory of the Laboratory. The specimen signature of the Authorized Signatory should be submitted to the corporation along with the tender. 6. The tender will be rejected if:- (a) A Laboratory submits conditional tender. (b) All the papers are not complete. (c) Providing incorrect/false information 7. The Item quoted will be rejected if: 7.1 More than one type of rates is quoted for one Item.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    112 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us